Pharmaron Beijing Co., Ltd.
SZSE:300759.SZ
27.61 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 1,601.096 | 1,352.137 | 1,620.077 | 1,146.992 | 530.674 | 339.026 | 227.024 | 176.912 | 73.846 | 20.995 |
| Depreciation & Amortization
| 1,008.588 | 696.18 | 497.92 | 375.162 | 317.667 | 211.695 | 144.634 | 92.883 | 63.69 | 51.259 |
| Deferred Income Tax
| -63.631 | -177.175 | -67.529 | 28.444 | -11.523 | 13.663 | 0 | 0 | 2.303 | 5.256 |
| Stock Based Compensation
| 202.222 | 177.175 | 67.529 | 62.458 | 11.523 | 0 | 0 | 22.007 | 31.019 | 8.186 |
| Change In Working Capital
| 63.666 | -346.465 | 130.039 | 234.586 | -61.12 | 43.072 | 66.692 | -106.763 | 1.359 | -109.216 |
| Accounts Receivables
| -480.104 | -786.73 | -216.308 | -95.348 | -286.412 | -173.776 | -133.894 | -114.984 | -31.491 | -91.887 |
| Inventory
| 82.43 | -120.891 | -224.875 | -120.047 | -37.956 | -28.289 | -1.362 | -45.551 | -18.443 | -13.368 |
| Accounts Payables
| 461.34 | 78.804 | 114.703 | 421.538 | 8.07 | 231.475 | 17.55 | 8.644 | 48.991 | 0 |
| Other Working Capital
| -0 | 482.352 | 456.519 | 28.444 | 255.178 | 71.361 | 68.055 | -61.211 | 19.802 | -95.848 |
| Other Non Cash Items
| 2,146.812 | 440.965 | -189.992 | -199.031 | 151.366 | 143.466 | 113.865 | 72.735 | 78.043 | 35.654 |
| Operating Cash Flow
| 2,803.02 | 2,142.816 | 2,058.044 | 1,648.61 | 938.586 | 737.258 | 552.215 | 235.768 | 216.939 | 12.135 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -2,865.321 | -2,949.861 | -2,092.822 | -1,315.838 | -754.606 | -640.986 | -934.667 | -1,055.489 | -258.323 | -81.939 |
| Acquisitions Net
| 961.366 | -1,021.838 | -1,230.528 | -791.521 | -59.497 | 22.382 | -345.604 | -80.731 | -222.639 | 0 |
| Purchases Of Investments
| -2,113.837 | -2,336.011 | -4,928.177 | -2,635.72 | -693.94 | -95.997 | 0 | -3.27 | 0 | 0 |
| Sales Maturities Of Investments
| 2,670.731 | 4,096.013 | 2,987.89 | 1,390.578 | 491.34 | 0 | 0 | 1,055.898 | 0 | 0 |
| Other Investing Activites
| -0.668 | 3.155 | 5.49 | -18.55 | -28.501 | 22.382 | 0.359 | -1,055.489 | 0.073 | 0.005 |
| Investing Cash Flow
| -1,347.061 | -2,208.542 | -5,258.147 | -3,371.051 | -1,045.204 | -714.6 | -1,279.911 | -1,139.081 | -480.889 | -81.934 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -3,611.74 | -612.579 | -158.555 | -760.963 | -1,289.314 | -423.681 | -219.825 | -147.479 | -138.215 | -108.578 |
| Common Stock Issued
| -207.946 | 7.294 | -295.546 | -13.149 | 5,054.514 | 0 | 0 | 881.378 | 0 | 0 |
| Common Stock Repurchased
| -0.83 | -393.384 | -284.058 | 13.149 | -5,054.514 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -357.346 | -354.192 | -237.546 | -119.138 | -72.192 | -74.595 | -60.599 | -14.414 | -15.922 | -14.899 |
| Other Financing Activities
| 7,139.871 | -13.834 | 4,684.269 | 616.188 | 5,678.384 | 482.718 | 852.659 | 1,442.859 | 452.27 | 165.581 |
| Financing Cash Flow
| 2,962.009 | -1,417.264 | 3,661.395 | -280.178 | 4,245.88 | -15.558 | 572.235 | 1,280.966 | 298.133 | 42.103 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 11.434 | 72.993 | -45.516 | -85.666 | -4.279 | 6.534 | -12.881 | 9.304 | 2.577 | 0.9 |
| Net Change In Cash
| 4,421.431 | -1,409.997 | 415.776 | -2,088.284 | 4,134.983 | 13.634 | -168.342 | 386.956 | 36.759 | -26.796 |
| Cash At End Of Period
| 5,918.915 | 1,359.713 | 2,769.709 | 2,353.934 | 4,442.218 | 307.235 | 293.601 | 461.944 | 74.987 | 38.228 |